Biomarker and companion diagnostic testing - Insights

Browse our suite of diagnostic, therapeutic and prognostic, quantitative and semi-quantitative immunohistochemical stains with interpretation.

New tests launched in January - Insights

In January 2023, Mayo Clinic Laboratories announced fifty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Oncology Testing - Mayo Clinic Laboratories

Our comprehensive test menu includes testing to aid in providing both diagnostic and prognostic information and aid in the treatment selection across the full spectrum of malignancies.

MayoComplete - Insights

Find out how our suite of MayoComplete next-generation sequencing panels puts patients on the right treatment path.

Phlebotomy Top Gun: Drawing Blood from a Patient Receiving Intravenous Fluids - Insights

In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., presents a case-based scenario on drawing blood from a patient receiving intravenous fluids.

Personal journey shapes unique perspective: Linda Hasadsri, M.D., Ph.D. - Insights

Dr. Linda Hasadsri’s firsthand encounter with the genetic tests she’s helped develop has provided rare insight into testing quality and implications, enhancing their ability to advocate for the value of testing and infusing their work with...

New test distinguishes between prion disease and other causes of rapidly progressive dementia - Insights

Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.

Genetics - Mayo Clinic Laboratories

Our genetic testing was developed by experienced geneticists, genetic counselors, laboratory scientists, and bioinformaticians. We focus on providing easy to understand answers, interpreted by those same individuals who have an intimate...

Driving change in women's health testing through pioneering research and novel testing strategies - Insights

New diagnostic tests specifically for conditions that predominantly or only affect women, such as autoimmune diseases and gynecological cancers, are empowering female patients and their physicians to make informed decisions.

GeoBioMed: How geologic rock formations inform novel treatments for kidney stones - Part I - Insights

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.